- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic immune (idiopathic) thrombocytopenia purpura
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 835KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 138KB)
Avatrombopag – November 2022
Avatrombopag: Tablet 20 mg; Doptelet®
Last updated
3 March 2023